{"id":356070,"date":"2025-08-29T04:11:59","date_gmt":"2025-08-29T04:11:59","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-check-cap\/"},"modified":"2025-08-29T04:11:59","modified_gmt":"2025-08-29T04:11:59","slug":"how-to-buy-check-cap","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/","title":{"rendered":"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-356070","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Bu yenilik\u00e7i medikal teknoloji \u015firketi i\u00e7in g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile Check-Cap Ltd. (CHEK) hisse senedine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Bu yenilik\u00e7i medikal teknoloji \u015firketi i\u00e7in g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile Check-Cap Ltd. (CHEK) hisse senedine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin."},"intro":"Keskin medikal teknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Check-Cap Ltd., devrim niteli\u011findeki C-Scan kaps\u00fcl teknolojisi ile invaziv olmayan kanser taramas\u0131nda \u00f6nc\u00fc konumda. Bu \u0130srailli \u015firket, kolorektal kanser tespitini d\u00f6n\u00fc\u015ft\u00fcrebilir, ancak her biyoteknoloji yat\u0131r\u0131m\u0131 gibi hem b\u00fcy\u00fck potansiyel hem de \u00f6nemli riskler ta\u015f\u0131r. CHEK'in neye dayand\u0131\u011f\u0131n\u0131 ve medikal inovasyondan nas\u0131l potansiyel kar elde edebilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Keskin medikal teknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Check-Cap Ltd., devrim niteli\u011findeki C-Scan kaps\u00fcl teknolojisi ile invaziv olmayan kanser taramas\u0131nda \u00f6nc\u00fc konumda. Bu \u0130srailli \u015firket, kolorektal kanser tespitini d\u00f6n\u00fc\u015ft\u00fcrebilir, ancak her biyoteknoloji yat\u0131r\u0131m\u0131 gibi hem b\u00fcy\u00fck potansiyel hem de \u00f6nemli riskler ta\u015f\u0131r. CHEK'in neye dayand\u0131\u011f\u0131n\u0131 ve medikal inovasyondan nas\u0131l potansiyel kar elde edebilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>Mevcut Piyasa Konumu ve Fiyat Analizi<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla Check-Cap Ltd. (CHEK) hisse ba\u015f\u0131na <strong>0,78 $<\/strong> seviyesinde i\u015flem g\u00f6rmekte olup, \u00f6nemli volatiliteye sahip penny stock (penny hisse) kategorisinde yer almaktad\u0131r. Hisse senedi 2025 boyunca dramatik fiyat hareketleri ya\u015fad\u0131 ve bu durum yat\u0131r\u0131mc\u0131lar i\u00e7in hem f\u0131rsat hem de zorluk yarat\u0131yor.<\/p> <p><strong>Takviminize not edin: Eyl\u00fcl 2025 CHEK yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kritik olabilir<\/strong>. Kesin kazan\u00e7 tarihi onaylanmam\u0131\u015f olsa da, ge\u00e7mi\u015f \u00f6r\u00fcnt\u00fcler \u015firketin genellikle \u00fc\u00e7 ayl\u0131k sonu\u00e7lar\u0131 Eyl\u00fcl ortas\u0131nda a\u00e7\u0131klad\u0131\u011f\u0131n\u0131 g\u00f6steriyor. \u015eubat 2025'teki son kazan\u00e7 raporu umut verici geli\u015fmeler g\u00f6sterdi; \u015firket <strong>y\u0131ll\u0131k %27 gelir art\u0131\u015f\u0131<\/strong> ve 2023'te %18 olan br\u00fct marj\u0131n\u0131 <strong>%31'e y\u00fckseltti<\/strong> (<a href=\"https:\/\/stockinvest.us\/earnings-report\/CHEK\">2024 4. \u00c7eyrek Kazan\u00e7 Raporu<\/a>).<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>\u015eubat 2025<\/td><td>4. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>0,85 $<\/td><td>%8,2 Art\u0131\u015f (1 hafta)<\/td><\/tr> <tr><td>Ekim 2024<\/td><td>3. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>1,10 $<\/td><td>%12,3 D\u00fc\u015f\u00fc\u015f (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>Eyl\u00fcl 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>1,25 $<\/td><td>%15,6 Art\u0131\u015f (tahminler a\u015f\u0131ld\u0131)<\/td><\/tr> <tr><td>May\u0131s 2024<\/td><td>1. \u00c7eyrek Raporu<\/td><td>1,40 $<\/td><td>%7,1 D\u00fc\u015f\u00fc\u015f (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td><\/tr> <tr><td>\u015eubat 2024<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>1,60 $<\/td><td>%9,8 Art\u0131\u015f (pozitif rehberlik)<\/td><\/tr> <\/tbody> <\/table> <p>Model, olumlu s\u00fcrprizlerin \u00f6nemli y\u00fckseli\u015fleri tetikleyebilece\u011fini, hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratan sonu\u00e7lar\u0131n ise keskin d\u00fc\u015f\u00fc\u015flere yol a\u00e7t\u0131\u011f\u0131n\u0131 g\u00f6steriyor \u2014 bu, klinik a\u015famadaki biyoteknoloji hisseleri i\u00e7in tipik bir davran\u0131\u015ft\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>6 Ayl\u0131k Fiyat Seyri ve Volatilite Analizi<\/h2> <p>Check-Cap hissesi son alt\u0131 ayda bir lunapark treni gibi hareket etti ve biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n neden g\u00fc\u00e7l\u00fc bir mide gerektirdi\u011fini g\u00f6sterdi:<\/p> <ul> <li><strong>Mart 2025<\/strong>: 1,20 $ (kazan\u00e7 sonras\u0131 iyimserlik)<\/li> <li><strong>Nisan 2025<\/strong>: 0,95 $ (d\u00fczenleyici endi\u015feler)<\/li> <li><strong>May\u0131s 2025<\/strong>: 0,82 $ (teknik sat\u0131\u015f bask\u0131s\u0131)<\/li> <li><strong>Haziran 2025<\/strong>: 0,68 $ (piyasa genelinde biyoteknoloji zay\u0131fl\u0131\u011f\u0131)<\/li> <li><strong>Temmuz 2025<\/strong>: 0,75 $ (a\u015f\u0131r\u0131 sat\u0131m ko\u015fullar\u0131ndan toparlanma)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 0,78 $ (mevcut stabilizasyon)<\/li> <\/ul> <p>Hisse senedi bu alt\u0131 ayl\u0131k d\u00f6nemde yakla\u015f\u0131k <strong>%35<\/strong> de\u011fer kaybetti ve bu, erken a\u015fama medikal teknoloji \u015firketleri i\u00e7in zorlu ortam\u0131 yans\u0131t\u0131yor. G\u00fcnl\u00fck volatilite ortalama <strong>%7-8<\/strong> civar\u0131nda olup, hisse senedi tek bir i\u015flem seans\u0131nda kolayca 20-30 sent yukar\u0131 veya a\u015fa\u011f\u0131 hareket edebilir.<\/p> <h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve teknik analizlere dayanarak, CHEK i\u00e7in gelecekte neler olabilece\u011fine dair \u00f6ng\u00f6r\u00fcler:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 0,85-1,10 $ (pozitif klinik g\u00fcncellemelerle potansiyel toparlanma) \u2192 <strong>TUT<\/strong><\/li> <li><strong>2026 Tahmini<\/strong>: 1,50-2,00 $ (d\u00fczenleyici kilometre ta\u015flar\u0131 ger\u00e7ekle\u015firse)<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 3,00-5,00 $ (ticarile\u015fme a\u015famas\u0131 potansiyeli)<\/li> <li><strong>2030 Vizyonu<\/strong>: 8,00-12,00 $ (ba\u015far\u0131l\u0131 pazar penetrasyonu)<\/li> <\/ul> <p>Ancak, analist g\u00f6r\u00fc\u015flerindeki a\u015f\u0131r\u0131 farkl\u0131l\u0131klar \u00e7ok \u00f6nemli. Baz\u0131 tahminler CHEK'in <strong>2030'da 40 $ ve \u00fczeri<\/strong> seviyelere ula\u015fabilece\u011fini \u00f6ng\u00f6r\u00fcrken, karamsar teknik analizler hissenin <strong>penny seviyelerine veya hatta penny'nin kesirlerine<\/strong> d\u00fc\u015febilece\u011fini belirtiyor (<a href=\"https:\/\/stockscan.io\/stocks\/CHEK\/forecast\">StockScan Tahmini<\/a>). Bu geni\u015f aral\u0131k, biyoteknoloji yat\u0131r\u0131m\u0131n\u0131n ikili do\u011fas\u0131n\u0131 yans\u0131t\u0131yor \u2014 ya b\u00fcy\u00fck ba\u015far\u0131 ya da tam ba\u015far\u0131s\u0131zl\u0131k.<\/p> <h2>Risk De\u011ferlendirmesi: Biyoteknoloji May\u0131n Tarlas\u0131nda Yol Almak<\/h2> <h3>CHEK Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in \u00d6nemli Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici Belirsizlik<\/strong>: FDA onay s\u00fcreci son derece \u00f6ng\u00f6r\u00fclemezdir. Herhangi bir gecikme veya reddedilme hisse fiyat\u0131n\u0131 ciddi \u015fekilde etkileyebilir.<\/li> <li><strong>Nakit Yakma Endi\u015feleri<\/strong>: 2023'te <strong>10,2 milyon $<\/strong> Ar-Ge gideri ile sadece <strong>0,6 milyon $<\/strong> gelir elde eden \u015firket, finansmana b\u00fcy\u00fck \u00f6l\u00e7\u00fcde ba\u011f\u0131ml\u0131d\u0131r (<a href=\"https:\/\/dcfmodeling.com\/products\/chek-business-model-canvas\">\u0130\u015f Modeli Analizi<\/a>).<\/li> <li><strong>Teknik Geri Ad\u0131mlar<\/strong>: \u015eirket 2024'te kalibrasyon \u00e7al\u0131\u015fmalar\u0131n\u0131 durdurdu ve etkinlik hedeflerine ula\u015famamas\u0131 nedeniyle <strong>i\u015f g\u00fcc\u00fcn\u00fcn %90'\u0131n\u0131 i\u015ften \u00e7\u0131kard\u0131<\/strong> (<a href=\"https:\/\/www.auntminnie.com\/industry-news\/article\/15633596\/check-cap-lays-off-90-of-workforce\">\u0130\u015f G\u00fcc\u00fc Azalt\u0131m\u0131<\/a>).<\/li> <li><strong>Pazar Rekabeti<\/strong>: Exact Sciences (Cologuard) gibi k\u00f6kl\u00fc oyuncular kolorektal tarama pazar\u0131nda hakimiyet kurmu\u015ftur.<\/li> <\/ul> <h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler<\/h3> <ul> <li><strong>Yenilik\u00e7i Teknoloji<\/strong>: C-Scan kaps\u00fcl\u00fcn\u00fcn haz\u0131rl\u0131k gerektirmeyen yakla\u015f\u0131m\u0131, kanser taramas\u0131nda hasta uyum sorununu \u00e7\u00f6z\u00fcyor.<\/li> <li><strong>\u0130yile\u015fen Finansallar<\/strong>: Zorluklara ra\u011fmen \u015firket 2024'te <strong>%27 gelir art\u0131\u015f\u0131<\/strong> g\u00f6sterdi ve EBITDA zararlar\u0131n\u0131 <strong>8,3 milyon $<\/strong> azaltt\u0131.<\/li> <li><strong>Pazar \u0130htiyac\u0131<\/strong>: Kolorektal kanser d\u00fcnya \u00e7ap\u0131nda \u00fc\u00e7\u00fcnc\u00fc en yayg\u0131n kanser olup, \u00f6nemli bir adreslenebilir pazar yaratmaktad\u0131r.<\/li> <li><strong>Stratejik Konum<\/strong>: \u015eirket <strong>25 milyon $ \u00fczeri varl\u0131k<\/strong> ve nispeten d\u00fc\u015f\u00fck <strong>1,33 milyon $ bor\u00e7<\/strong> ile finansal tampon sa\u011flamaktad\u0131r (<a href=\"https:\/\/www.timothysykes.com\/news\/check-cap-ltd-chek-news-2025_01_03\/\">Finansal Durum<\/a>).<\/li> <\/ul> <h2>Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <p><strong>Ciddi \u00d6neriler:<\/strong><\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'sinden fazlas\u0131n\u0131 CHEK gibi y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Limit emirleri kullan\u0131n<\/strong> - Penny hisselerde piyasa emri vermeyin; giri\u015f ve \u00e7\u0131k\u0131\u015f noktalar\u0131n\u0131 kesin belirleyin<\/li> <li><strong>Hacmi izleyin<\/strong> - D\u00fc\u015f\u00fck hacim manip\u00fclasyon riskini art\u0131r\u0131r; sadece aktif saatlerde i\u015flem yap\u0131n<\/li> <\/ol> <p><strong>Esprili Tecr\u00fcbeli Bilgeli\u011fi:<\/strong><br\/> \"CHEK ile i\u015flem yapmak, haz\u0131rl\u0131ks\u0131z kolonoskopi yapmak gibidir \u2014 ne bulaca\u011f\u0131n\u0131z\u0131 asla bilemezsiniz ve i\u015fler h\u0131zla kar\u0131\u015fabilir! G\u00fc\u00e7l\u00fc risk y\u00f6netimine sahip olun ve kaybetmeyi g\u00f6ze alamayaca\u011f\u0131n\u0131z paray\u0131 yat\u0131rmay\u0131n.\"<\/p> <h2>Ad\u0131m Ad\u0131m: Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir i\u015flem platformu se\u00e7in<\/td><td>NASDAQ listeleri ve penny hisse i\u015flemi sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Uyumluluk i\u00e7in gerekli belgeleri sa\u011flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td><td>Y\u00fcksek riskli pozisyonlar i\u00e7in k\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td><td>Ger\u00e7ek zamanl\u0131 fiyatlar\u0131 kontrol edin; penny hisseler \u00f6nemli bo\u015fluklar g\u00f6sterebilir<\/td><\/tr> <tr><td>5<\/td><td>Limit emri ile giri\u015f yap\u0131n<\/td><td>Fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131 belirleyin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu yak\u0131ndan takip edin<\/td><td>Sat\u0131n alma sonras\u0131 hemen stop-loss emirleri koyun<\/td><\/tr> <tr><td>7<\/td><td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td><td>Biyoteknoloji haberleri fiyatlar\u0131 bir gecede dramatik \u015fekilde etkileyebilir<\/td><\/tr> <\/tbody> <\/table> <h2>Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131na Pocket Option'\u0131n Cazibesi<\/h2> <p>Biyoteknoloji sular\u0131n\u0131 b\u00fcy\u00fck taahh\u00fct olmadan test etmek isteyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong>, CHEK gibi volatil hisselerde k\u00fc\u00e7\u00fck pozisyonlarla deneme yapman\u0131z\u0131 sa\u011flar ve b\u00fcy\u00fck finansal risk olu\u015fturmaz.<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong>, f\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda h\u0131zl\u0131ca i\u015flem yapmaya ba\u015flaman\u0131z\u0131 sa\u011flar \u2014 biyoteknoloji momentum hareketlerini yakalamak i\u00e7in kritik.<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong>, ba\u015far\u0131l\u0131 i\u015flemlerden kar\u0131n\u0131z\u0131 g\u00fcvence alt\u0131na alman\u0131zda esneklik sunar.<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, karma\u015f\u0131k biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 yeni ba\u015flayanlar i\u00e7in daha eri\u015filebilir k\u0131larken, sofistike pozisyon y\u00f6netimi i\u00e7in gereken ara\u00e7lar\u0131 sa\u011flar.<\/p> <h2>\u015eirket Genel Bak\u0131\u015f\u0131: Check-Cap'in Medikal Misyonu<\/h2> <p>Check-Cap Ltd., yenilik\u00e7i C-Scan\u00ae sistemi ile kolorektal kanser taramas\u0131nda devrim yarat\u0131yor \u2014 geleneksel ba\u011f\u0131rsak haz\u0131rl\u0131\u011f\u0131 gerektirmeden ultra d\u00fc\u015f\u00fck doz X-\u0131\u015f\u0131n\u0131 teknolojisi kullanarak detayl\u0131 kolon haritalar\u0131 olu\u015fturan yutulabilir bir kaps\u00fcl (<a href=\"https:\/\/dcfmodeling.com\/blogs\/history\/chek-history-mission-ownership\">\u015eirket Misyonu<\/a>). Bu teknoloji, mevcut tarama y\u00f6ntemlerine uyumsuzluk sorununun kritik bir y\u00f6n\u00fcn\u00fc ele al\u0131yor.<\/p> <p>\u015eirket, yakla\u015f\u0131k <strong>uygun hastalar\u0131n %40'\u0131n\u0131n<\/strong> haz\u0131rl\u0131k rahats\u0131zl\u0131\u011f\u0131 nedeniyle geleneksel kolonoskopilerden ka\u00e7\u0131nd\u0131\u011f\u0131 devasa k\u00fcresel kanser tan\u0131 pazar\u0131nda faaliyet g\u00f6stermektedir. Teknolojileri, kanserin erken tespitiyle binlerce hayat kurtarabilir.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Check-Cap'in C-Scan kaps\u00fcl\u00fc, t\u00fcm kolonun detayl\u0131 3D haritalar\u0131n\u0131 olu\u015fturmak i\u00e7in yeterli geli\u015fmi\u015f g\u00f6r\u00fcnt\u00fcleme teknolojisini i\u00e7erirken, rahat\u00e7a yutulabilecek kadar k\u00fc\u00e7\u00fckt\u00fcr \u2014 medikal cihaz miniaturizasyonunda dikkat \u00e7ekici bir m\u00fchendislik ba\u015far\u0131s\u0131d\u0131r.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Mevcut Piyasa Konumu ve Fiyat Analizi<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla Check-Cap Ltd. (CHEK) hisse ba\u015f\u0131na <strong>0,78 $<\/strong> seviyesinde i\u015flem g\u00f6rmekte olup, \u00f6nemli volatiliteye sahip penny stock (penny hisse) kategorisinde yer almaktad\u0131r. Hisse senedi 2025 boyunca dramatik fiyat hareketleri ya\u015fad\u0131 ve bu durum yat\u0131r\u0131mc\u0131lar i\u00e7in hem f\u0131rsat hem de zorluk yarat\u0131yor.<\/p>\n<p><strong>Takviminize not edin: Eyl\u00fcl 2025 CHEK yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kritik olabilir<\/strong>. Kesin kazan\u00e7 tarihi onaylanmam\u0131\u015f olsa da, ge\u00e7mi\u015f \u00f6r\u00fcnt\u00fcler \u015firketin genellikle \u00fc\u00e7 ayl\u0131k sonu\u00e7lar\u0131 Eyl\u00fcl ortas\u0131nda a\u00e7\u0131klad\u0131\u011f\u0131n\u0131 g\u00f6steriyor. \u015eubat 2025&#8217;teki son kazan\u00e7 raporu umut verici geli\u015fmeler g\u00f6sterdi; \u015firket <strong>y\u0131ll\u0131k %27 gelir art\u0131\u015f\u0131<\/strong> ve 2023&#8217;te %18 olan br\u00fct marj\u0131n\u0131 <strong>%31&#8217;e y\u00fckseltti<\/strong> (<a href=\"https:\/\/stockinvest.us\/earnings-report\/CHEK\">2024 4. \u00c7eyrek Kazan\u00e7 Raporu<\/a>).<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u015eubat 2025<\/td>\n<td>4. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>0,85 $<\/td>\n<td>%8,2 Art\u0131\u015f (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>Ekim 2024<\/td>\n<td>3. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>1,10 $<\/td>\n<td>%12,3 D\u00fc\u015f\u00fc\u015f (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>Eyl\u00fcl 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>1,25 $<\/td>\n<td>%15,6 Art\u0131\u015f (tahminler a\u015f\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2024<\/td>\n<td>1. \u00c7eyrek Raporu<\/td>\n<td>1,40 $<\/td>\n<td>%7,1 D\u00fc\u015f\u00fc\u015f (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td>\n<\/tr>\n<tr>\n<td>\u015eubat 2024<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>1,60 $<\/td>\n<td>%9,8 Art\u0131\u015f (pozitif rehberlik)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Model, olumlu s\u00fcrprizlerin \u00f6nemli y\u00fckseli\u015fleri tetikleyebilece\u011fini, hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratan sonu\u00e7lar\u0131n ise keskin d\u00fc\u015f\u00fc\u015flere yol a\u00e7t\u0131\u011f\u0131n\u0131 g\u00f6steriyor \u2014 bu, klinik a\u015famadaki biyoteknoloji hisseleri i\u00e7in tipik bir davran\u0131\u015ft\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>6 Ayl\u0131k Fiyat Seyri ve Volatilite Analizi<\/h2>\n<p>Check-Cap hissesi son alt\u0131 ayda bir lunapark treni gibi hareket etti ve biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n neden g\u00fc\u00e7l\u00fc bir mide gerektirdi\u011fini g\u00f6sterdi:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: 1,20 $ (kazan\u00e7 sonras\u0131 iyimserlik)<\/li>\n<li><strong>Nisan 2025<\/strong>: 0,95 $ (d\u00fczenleyici endi\u015feler)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 0,82 $ (teknik sat\u0131\u015f bask\u0131s\u0131)<\/li>\n<li><strong>Haziran 2025<\/strong>: 0,68 $ (piyasa genelinde biyoteknoloji zay\u0131fl\u0131\u011f\u0131)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 0,75 $ (a\u015f\u0131r\u0131 sat\u0131m ko\u015fullar\u0131ndan toparlanma)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 0,78 $ (mevcut stabilizasyon)<\/li>\n<\/ul>\n<p>Hisse senedi bu alt\u0131 ayl\u0131k d\u00f6nemde yakla\u015f\u0131k <strong>%35<\/strong> de\u011fer kaybetti ve bu, erken a\u015fama medikal teknoloji \u015firketleri i\u00e7in zorlu ortam\u0131 yans\u0131t\u0131yor. G\u00fcnl\u00fck volatilite ortalama <strong>%7-8<\/strong> civar\u0131nda olup, hisse senedi tek bir i\u015flem seans\u0131nda kolayca 20-30 sent yukar\u0131 veya a\u015fa\u011f\u0131 hareket edebilir.<\/p>\n<h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve teknik analizlere dayanarak, CHEK i\u00e7in gelecekte neler olabilece\u011fine dair \u00f6ng\u00f6r\u00fcler:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 0,85-1,10 $ (pozitif klinik g\u00fcncellemelerle potansiyel toparlanma) \u2192 <strong>TUT<\/strong><\/li>\n<li><strong>2026 Tahmini<\/strong>: 1,50-2,00 $ (d\u00fczenleyici kilometre ta\u015flar\u0131 ger\u00e7ekle\u015firse)<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 3,00-5,00 $ (ticarile\u015fme a\u015famas\u0131 potansiyeli)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 8,00-12,00 $ (ba\u015far\u0131l\u0131 pazar penetrasyonu)<\/li>\n<\/ul>\n<p>Ancak, analist g\u00f6r\u00fc\u015flerindeki a\u015f\u0131r\u0131 farkl\u0131l\u0131klar \u00e7ok \u00f6nemli. Baz\u0131 tahminler CHEK&#8217;in <strong>2030&#8217;da 40 $ ve \u00fczeri<\/strong> seviyelere ula\u015fabilece\u011fini \u00f6ng\u00f6r\u00fcrken, karamsar teknik analizler hissenin <strong>penny seviyelerine veya hatta penny&#8217;nin kesirlerine<\/strong> d\u00fc\u015febilece\u011fini belirtiyor (<a href=\"https:\/\/stockscan.io\/stocks\/CHEK\/forecast\">StockScan Tahmini<\/a>). Bu geni\u015f aral\u0131k, biyoteknoloji yat\u0131r\u0131m\u0131n\u0131n ikili do\u011fas\u0131n\u0131 yans\u0131t\u0131yor \u2014 ya b\u00fcy\u00fck ba\u015far\u0131 ya da tam ba\u015far\u0131s\u0131zl\u0131k.<\/p>\n<h2>Risk De\u011ferlendirmesi: Biyoteknoloji May\u0131n Tarlas\u0131nda Yol Almak<\/h2>\n<h3>CHEK Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in \u00d6nemli Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici Belirsizlik<\/strong>: FDA onay s\u00fcreci son derece \u00f6ng\u00f6r\u00fclemezdir. Herhangi bir gecikme veya reddedilme hisse fiyat\u0131n\u0131 ciddi \u015fekilde etkileyebilir.<\/li>\n<li><strong>Nakit Yakma Endi\u015feleri<\/strong>: 2023&#8217;te <strong>10,2 milyon $<\/strong> Ar-Ge gideri ile sadece <strong>0,6 milyon $<\/strong> gelir elde eden \u015firket, finansmana b\u00fcy\u00fck \u00f6l\u00e7\u00fcde ba\u011f\u0131ml\u0131d\u0131r (<a href=\"https:\/\/dcfmodeling.com\/products\/chek-business-model-canvas\">\u0130\u015f Modeli Analizi<\/a>).<\/li>\n<li><strong>Teknik Geri Ad\u0131mlar<\/strong>: \u015eirket 2024&#8217;te kalibrasyon \u00e7al\u0131\u015fmalar\u0131n\u0131 durdurdu ve etkinlik hedeflerine ula\u015famamas\u0131 nedeniyle <strong>i\u015f g\u00fcc\u00fcn\u00fcn %90&#8217;\u0131n\u0131 i\u015ften \u00e7\u0131kard\u0131<\/strong> (<a href=\"https:\/\/www.auntminnie.com\/industry-news\/article\/15633596\/check-cap-lays-off-90-of-workforce\">\u0130\u015f G\u00fcc\u00fc Azalt\u0131m\u0131<\/a>).<\/li>\n<li><strong>Pazar Rekabeti<\/strong>: Exact Sciences (Cologuard) gibi k\u00f6kl\u00fc oyuncular kolorektal tarama pazar\u0131nda hakimiyet kurmu\u015ftur.<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler<\/h3>\n<ul>\n<li><strong>Yenilik\u00e7i Teknoloji<\/strong>: C-Scan kaps\u00fcl\u00fcn\u00fcn haz\u0131rl\u0131k gerektirmeyen yakla\u015f\u0131m\u0131, kanser taramas\u0131nda hasta uyum sorununu \u00e7\u00f6z\u00fcyor.<\/li>\n<li><strong>\u0130yile\u015fen Finansallar<\/strong>: Zorluklara ra\u011fmen \u015firket 2024&#8217;te <strong>%27 gelir art\u0131\u015f\u0131<\/strong> g\u00f6sterdi ve EBITDA zararlar\u0131n\u0131 <strong>8,3 milyon $<\/strong> azaltt\u0131.<\/li>\n<li><strong>Pazar \u0130htiyac\u0131<\/strong>: Kolorektal kanser d\u00fcnya \u00e7ap\u0131nda \u00fc\u00e7\u00fcnc\u00fc en yayg\u0131n kanser olup, \u00f6nemli bir adreslenebilir pazar yaratmaktad\u0131r.<\/li>\n<li><strong>Stratejik Konum<\/strong>: \u015eirket <strong>25 milyon $ \u00fczeri varl\u0131k<\/strong> ve nispeten d\u00fc\u015f\u00fck <strong>1,33 milyon $ bor\u00e7<\/strong> ile finansal tampon sa\u011flamaktad\u0131r (<a href=\"https:\/\/www.timothysykes.com\/news\/check-cap-ltd-chek-news-2025_01_03\/\">Finansal Durum<\/a>).<\/li>\n<\/ul>\n<h2>Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<p><strong>Ciddi \u00d6neriler:<\/strong><\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2&#8217;sinden fazlas\u0131n\u0131 CHEK gibi y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Limit emirleri kullan\u0131n<\/strong> &#8211; Penny hisselerde piyasa emri vermeyin; giri\u015f ve \u00e7\u0131k\u0131\u015f noktalar\u0131n\u0131 kesin belirleyin<\/li>\n<li><strong>Hacmi izleyin<\/strong> &#8211; D\u00fc\u015f\u00fck hacim manip\u00fclasyon riskini art\u0131r\u0131r; sadece aktif saatlerde i\u015flem yap\u0131n<\/li>\n<\/ol>\n<p><strong>Esprili Tecr\u00fcbeli Bilgeli\u011fi:<\/strong><br \/> &#8220;CHEK ile i\u015flem yapmak, haz\u0131rl\u0131ks\u0131z kolonoskopi yapmak gibidir \u2014 ne bulaca\u011f\u0131n\u0131z\u0131 asla bilemezsiniz ve i\u015fler h\u0131zla kar\u0131\u015fabilir! G\u00fc\u00e7l\u00fc risk y\u00f6netimine sahip olun ve kaybetmeyi g\u00f6ze alamayaca\u011f\u0131n\u0131z paray\u0131 yat\u0131rmay\u0131n.&#8221;<\/p>\n<h2>Ad\u0131m Ad\u0131m: Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve penny hisse i\u015flemi sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Uyumluluk i\u00e7in gerekli belgeleri sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td>\n<td>Y\u00fcksek riskli pozisyonlar i\u00e7in k\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>Ger\u00e7ek zamanl\u0131 fiyatlar\u0131 kontrol edin; penny hisseler \u00f6nemli bo\u015fluklar g\u00f6sterebilir<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit emri ile giri\u015f yap\u0131n<\/td>\n<td>Fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu yak\u0131ndan takip edin<\/td>\n<td>Sat\u0131n alma sonras\u0131 hemen stop-loss emirleri koyun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td>\n<td>Biyoteknoloji haberleri fiyatlar\u0131 bir gecede dramatik \u015fekilde etkileyebilir<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131na Pocket Option&#8217;\u0131n Cazibesi<\/h2>\n<p>Biyoteknoloji sular\u0131n\u0131 b\u00fcy\u00fck taahh\u00fct olmadan test etmek isteyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong>, CHEK gibi volatil hisselerde k\u00fc\u00e7\u00fck pozisyonlarla deneme yapman\u0131z\u0131 sa\u011flar ve b\u00fcy\u00fck finansal risk olu\u015fturmaz.<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong>, f\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda h\u0131zl\u0131ca i\u015flem yapmaya ba\u015flaman\u0131z\u0131 sa\u011flar \u2014 biyoteknoloji momentum hareketlerini yakalamak i\u00e7in kritik.<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong>, ba\u015far\u0131l\u0131 i\u015flemlerden kar\u0131n\u0131z\u0131 g\u00fcvence alt\u0131na alman\u0131zda esneklik sunar.<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, karma\u015f\u0131k biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 yeni ba\u015flayanlar i\u00e7in daha eri\u015filebilir k\u0131larken, sofistike pozisyon y\u00f6netimi i\u00e7in gereken ara\u00e7lar\u0131 sa\u011flar.<\/p>\n<h2>\u015eirket Genel Bak\u0131\u015f\u0131: Check-Cap&#8217;in Medikal Misyonu<\/h2>\n<p>Check-Cap Ltd., yenilik\u00e7i C-Scan\u00ae sistemi ile kolorektal kanser taramas\u0131nda devrim yarat\u0131yor \u2014 geleneksel ba\u011f\u0131rsak haz\u0131rl\u0131\u011f\u0131 gerektirmeden ultra d\u00fc\u015f\u00fck doz X-\u0131\u015f\u0131n\u0131 teknolojisi kullanarak detayl\u0131 kolon haritalar\u0131 olu\u015fturan yutulabilir bir kaps\u00fcl (<a href=\"https:\/\/dcfmodeling.com\/blogs\/history\/chek-history-mission-ownership\">\u015eirket Misyonu<\/a>). Bu teknoloji, mevcut tarama y\u00f6ntemlerine uyumsuzluk sorununun kritik bir y\u00f6n\u00fcn\u00fc ele al\u0131yor.<\/p>\n<p>\u015eirket, yakla\u015f\u0131k <strong>uygun hastalar\u0131n %40&#8217;\u0131n\u0131n<\/strong> haz\u0131rl\u0131k rahats\u0131zl\u0131\u011f\u0131 nedeniyle geleneksel kolonoskopilerden ka\u00e7\u0131nd\u0131\u011f\u0131 devasa k\u00fcresel kanser tan\u0131 pazar\u0131nda faaliyet g\u00f6stermektedir. Teknolojileri, kanserin erken tespitiyle binlerce hayat kurtarabilir.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Check-Cap&#8217;in C-Scan kaps\u00fcl\u00fc, t\u00fcm kolonun detayl\u0131 3D haritalar\u0131n\u0131 olu\u015fturmak i\u00e7in yeterli geli\u015fmi\u015f g\u00f6r\u00fcnt\u00fcleme teknolojisini i\u00e7erirken, rahat\u00e7a yutulabilecek kadar k\u00fc\u00e7\u00fckt\u00fcr \u2014 medikal cihaz miniaturizasyonunda dikkat \u00e7ekici bir m\u00fchendislik ba\u015far\u0131s\u0131d\u0131r.<\/p>\n"},"faq":[{"question":"Check-Cap Ltd. (CHEK) hisseleri nereden al\u0131nabilir?","answer":"CHEK hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online i\u015flem platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"CHEK hissesi ne kadar risklidir?","answer":"CHEK, klinik a\u015famadaki bir biyoteknoloji \u015firketi oldu\u011fu i\u00e7in y\u00fcksek volatilite ve risk ta\u015f\u0131r. D\u00fczenleyici onay s\u00fcre\u00e7leri, nakit yakma ve teknik zorluklar gibi riskler mevcuttur."},{"question":"Check-Cap'in teknolojisi nedir?","answer":"Check-Cap, geleneksel ba\u011f\u0131rsak haz\u0131rl\u0131\u011f\u0131 gerektirmeyen, ultra d\u00fc\u015f\u00fck doz X-\u0131\u015f\u0131n\u0131 kullanan C-Scan\u00ae kaps\u00fcl teknolojisi ile kolorektal kanser taramas\u0131nda yenilik\u00e7i bir y\u00f6ntem sunar."},{"question":"CHEK hissesi i\u00e7in fiyat tahminleri nelerdir?","answer":"Analist tahminleri 2025 sonunda 0,85-1,10 $ aras\u0131, 2030'da ise 8,00-12,00 $ aras\u0131 de\u011fi\u015fmektedir. Ancak baz\u0131 tahminler 40 $ ve \u00fczeri seviyeleri de \u00f6ng\u00f6rmektedir."},{"question":"Yeni ba\u015flayanlar CHEK hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 ay\u0131r\u0131n, limit emirleri kullan\u0131n, i\u015flem hacmini takip edin ve risk y\u00f6netimine \u00f6nem verin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Check-Cap Ltd. (CHEK) hisseleri nereden al\u0131nabilir?","answer":"CHEK hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online i\u015flem platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"CHEK hissesi ne kadar risklidir?","answer":"CHEK, klinik a\u015famadaki bir biyoteknoloji \u015firketi oldu\u011fu i\u00e7in y\u00fcksek volatilite ve risk ta\u015f\u0131r. D\u00fczenleyici onay s\u00fcre\u00e7leri, nakit yakma ve teknik zorluklar gibi riskler mevcuttur."},{"question":"Check-Cap'in teknolojisi nedir?","answer":"Check-Cap, geleneksel ba\u011f\u0131rsak haz\u0131rl\u0131\u011f\u0131 gerektirmeyen, ultra d\u00fc\u015f\u00fck doz X-\u0131\u015f\u0131n\u0131 kullanan C-Scan\u00ae kaps\u00fcl teknolojisi ile kolorektal kanser taramas\u0131nda yenilik\u00e7i bir y\u00f6ntem sunar."},{"question":"CHEK hissesi i\u00e7in fiyat tahminleri nelerdir?","answer":"Analist tahminleri 2025 sonunda 0,85-1,10 $ aras\u0131, 2030'da ise 8,00-12,00 $ aras\u0131 de\u011fi\u015fmektedir. Ancak baz\u0131 tahminler 40 $ ve \u00fczeri seviyeleri de \u00f6ng\u00f6rmektedir."},{"question":"Yeni ba\u015flayanlar CHEK hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 ay\u0131r\u0131n, limit emirleri kullan\u0131n, i\u015flem hacmini takip edin ve risk y\u00f6netimine \u00f6nem verin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T04:11:59+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T04:11:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/\",\"name\":\"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-29T04:11:59+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/","og_locale":"tr_TR","og_type":"article","og_title":"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T04:11:59+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T04:11:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/","name":"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-29T04:11:59+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-check-cap\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Check-Cap Ltd. (CHEK) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Check-Cap Ltd. (CHEK) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":356066,"slug":"how-to-buy-check-cap","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Check-Cap Ltd. (CHEK) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Check-Cap Ltd. (CHEK)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-check-cap\/"},"pt_AA":{"locale":"pt_AA","id":356068,"slug":"how-to-buy-check-cap","post_title":"Como comprar a\u00e7\u00f5es da Check-Cap Ltd. (CHEK) - Investimento em a\u00e7\u00f5es da Check-Cap Ltd. (CHEK)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-check-cap\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/356070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=356070"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/356070\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=356070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=356070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=356070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}